Natco Pharma Ltd is quoting at Rs 1460.95, up 2.42% on the day as on 12:49 IST on the NSE. The stock is up 72.36% in last one year as compared to a 27.7% jump in NIFTY and a 57.37% jump in the Nifty ...

The Lagos State Government has urged artisans to adopt a proactive approach to safety and foster a culture of safety within ...

Natco Pharma share rose after the company announced that Mylan Pharmaceuticals Inc & Novo Nordisk have reached a settlement ...

Mylan Pharmaceuticals Inc and Novo Nordisk, the original patent holder for Ozempic, have reached a settlement in the US ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

Shares of Natco Pharma Ltd surged nearly 4.35 per cent to Rs 1,413.45 on Monday, commanding a total market capitalization ...

Natco Pharma shares rise 3% as partner Mylan settles U.S. patent litigation with Novo Nordisk for generic Ozempic.

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...

The convener of the conference, Dayo Bello, said NATCO would serve as a hub for establishing valuable contact between local ...

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

The strong up move was seen in the stock price with the scrip touching the day's high of Rs 1,408.70 per share on the NSE, ...

Hyderabad: NATCO Pharma Limited has announced that its partner Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a ...